On June 13, 2017, the President authorized the use of the Defense Production Act (DPA) Title III authority to address critical industrial base shortfalls related to four important technological capabilities in the fields of medicine, soldier protection, trade facilitation, and information security.
Adenovirus vaccine production and high strength co-polymer aramid fiber manufacturing increases warfighter readiness by strengthening the health of Service members and supporting technologies key to personal protective equipment.
Having access to secure hybrid composite shipping containers is also a critical piece of the President’s Determination, as it mandates the production of containers with six-sided intrusion detection and tracking, protecting American cargo abroad.
In addition, three-dimensional, ultra‑high density microelectronics for information protection is also identified as a key shortfall in the Presidential Determination. This technology can deter reverse engineering and exploitation of critical technology and critical program information by impeding technology transfer and stopping alteration of system capabilities.
Altogether, this Presidential Determination is an important achievement for the defense industrial base. Now that these shortfalls have been identified, the Office of the Deputy Assistant Secretary of Defense for Manufacturing and Industrial Base Policy will oversee the deployment of specialized mitigation strategies to ensure that these distinct challenges are met for the security of the nation.
To learn more about DPA Title III, please visit the DPA Title III page.
Please see the official White House memorandum for more information.